M

MicuRx Pharmaceuticals, Inc.

19 employees

MicuRx discovers and develops novel antimicrobials to treat drug-resistant infections and other diseases of significant unmet medical need

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Infectious diseases
Health Care
Medical

Date founded

2007

Funding rounds raised

Total raised

$107M

from 13 investors over 13 rounds

M

MicuRx Pharmaceuticals, Inc. raised $107M on December 21, 2020

Investors: Korea Investment Partners, Founder Securities Co., Ltd., Legend Capital and CMPort (China Merchants Group)

M

MicuRx Pharmaceuticals, Inc. raised $7.8M on August 13, 2020

Investors: CARB-X

M

MicuRx Pharmaceuticals, Inc. raised $43M on August 5, 2020

Investors: 华盖资本有限责任公司 and 清科集团

M

MicuRx Pharmaceuticals, Inc. raised $5.2M on March 5, 2018

Investors: CARB-X

M

MicuRx Pharmaceuticals, Inc. raised $15M on December 7, 2017

Investors: 北京德联运通投资管理有限公司 and BioVeda China Fund

M

MicuRx Pharmaceuticals, Inc. raised $55M on September 26, 2016

Investors: 3E Bioventures Capital

M

MicuRx Pharmaceuticals, Inc. raised $25M on August 22, 2013

Investors: Devon Park Bioventures and BioVeda China Fund

FAQ